325 related articles for article (PubMed ID: 30188580)
21. Experience with pre-diluted plasma exchange therapy for hyperviscosity syndrome.
Igarashi S; Kamikawa Y; Ono S; Maekawa G; Kishigami H; Kawamura K; Oonogi T; Nagano T
Ther Apher Dial; 2023 Dec; 27(6):1035-1039. PubMed ID: 37605348
[TBL] [Abstract][Full Text] [Related]
22. Double filtration plasmapheresis - 10-year pediatric experience as an alternative to plasma exchange.
Maxted AP; Connell R; Hussain F
Transfus Apher Sci; 2020 Dec; 59(6):102928. PubMed ID: 32919882
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey.
Kalpakci Y; Hacibekiroglu T; Darcin T; AkgunCagliyan G; Cakar MK; Hacioglu SK; Ekinci O; Korkmaz S; Albayrak M; Dal MS; Dogan A; Ulas T; Eser B; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103244. PubMed ID: 34462219
[TBL] [Abstract][Full Text] [Related]
24. Studies of the hyperviscosity syndrome. II. Macroglobulinemia.
MacKenzie MR; Babcock J
J Lab Clin Med; 1975 Feb; 85(2):227-34. PubMed ID: 803540
[TBL] [Abstract][Full Text] [Related]
25. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
26. Histidine based adsorbents for selective removal of monoclonal immunoglobulin IgM antibodies from Waldenstrom's macroglobulinemia patient sera: a preliminary study.
Srour M; Kassab I; Matta H; Elkak A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():1-5. PubMed ID: 23811496
[TBL] [Abstract][Full Text] [Related]
27. Double filtration plasmapheresis in critical care.
Mineshima M; Akiba T
Ther Apher; 2002 Jun; 6(3):180-3. PubMed ID: 12109939
[TBL] [Abstract][Full Text] [Related]
28. Double filtration plasmapheresis in different diseases in Thailand.
Lumlertgul D; Suteeka Y; Tumpong S; Bunnachak D; Boonkaew S
Ther Apher Dial; 2013 Feb; 17(1):99-116. PubMed ID: 23379501
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia.
Lawson NS; Nosanchuk JS; Oberman HA; Meyers MC
Transfusion; 1968; 8(3):174-8. PubMed ID: 4968993
[No Abstract] [Full Text] [Related]
30. Different cascade filtration operating modalities in clinical use.
Busnach G; Dal Col A; Brando B; Cappelleri A; Perrino ML; Brunati C; Minetti L
Int J Artif Organs; 1988 Nov; 11(6):493-6. PubMed ID: 3144514
[TBL] [Abstract][Full Text] [Related]
31. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.
Paglialonga F; Schmitt CP; Shroff R; Vondrak K; Aufricht C; Watson AR; Ariceta G; Fischbach M; Klaus G; Holtta T; Bakkaloglu SA; Zurowska A; Jankauskiene A; Vande Walle J; Schaefer B; Wright E; Connell R; Edefonti A
Pediatr Nephrol; 2015 Jan; 30(1):103-11. PubMed ID: 25135618
[TBL] [Abstract][Full Text] [Related]
32. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
33. Selective plasma exchange.
Ohkubo A; Okado T
Transfus Apher Sci; 2017 Oct; 56(5):657-660. PubMed ID: 28939369
[TBL] [Abstract][Full Text] [Related]
34. Current topics in therapeutic plasmapheresis.
Nakanishi T; Suzuki N; Kuragano T; Nagasawa Y; Hasuike Y
Clin Exp Nephrol; 2014 Feb; 18(1):41-9. PubMed ID: 23887747
[TBL] [Abstract][Full Text] [Related]
35. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.
Gustine JN; Meid K; Dubeau T; Hunter ZR; Xu L; Yang G; Ghobrial IM; Treon SP; Castillo JJ
Br J Haematol; 2017 Jun; 177(5):717-725. PubMed ID: 28485115
[TBL] [Abstract][Full Text] [Related]
36. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
Mullen EC; Wang M
Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
[TBL] [Abstract][Full Text] [Related]
37. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.
Beck JR; Quinn BM; Meier FA; Rawnsley HM
Transfusion; 1982; 22(1):51-3. PubMed ID: 6801828
[TBL] [Abstract][Full Text] [Related]
38. Continuous monitoring of blood volume in double filtration plasmapheresis.
Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
[TBL] [Abstract][Full Text] [Related]
39. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
40. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
